Prevalence of PLK1 Overexpression in Target Cancer Populations

bir ses eklendi Health

2024-11-11 06:13:41 -

The prevalence of PLK1 overexpression in various cancer types is a significant factor in the development and growth of the PLK1 inhibitors market. PLK1, a protein that regulates the cell cycle, is often overexpressed in cancers like breast, lung, prostate, and colorectal cancers. This overexpression is linked to cancer cell proliferation and poor patient prognosis, making PLK1 inhibitors...

0 Yorumlar 0 hisse senetleri 148 Views 0 önizleme